Botanical species · safety record

Terminalia chebula

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Terminalia chebula. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Terminalia chebula Retz.

4Constituent measurements

2Safety records

4Cited sources

364Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 364 licensed products naming Terminalia chebula as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Fresh
fluid

Source material stated

Dried fruit
Dried ripe fruit
Dried young fruit
Fruit
Fruit extract
Fruit flesh
Fruit mesocarp
Fruit peel

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gallic acid	Fruit unspecified	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Tannins	Fruit unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Fruit unspecified	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive: pancreas	Leaves	Solvent extraction	—	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Anam, K., Widharna, R. M., Kusrini, D. alpha-Glucosidase Inhibitor Activity of Terminalia Species. International journal of pharmacology, 2009, vol. 5, no. 4, p. 277-280.
Gao, Hong., Huang, Yi-Na., Xu, Pei-Yu., Kawabata, Jun. Inhibitory effect on alpha-glucosidase by the fruits of Terminalia chebula Retz. . Food chemistry, 2007, vol. 105, no. 2, p. 628-634. DOI
Kaur, S., Grover, IS., Singh, M., Kaur, S. Antimutagenicity of hydrolyzable tannins from Terminalia chebula in Salmonella typhimurium . Mutation research-genetic toxicology and environmental mutagenesis, 1998, vol. 419, no. 1-3, p. 169-179. DOI
LEE, SH., RYU, SY., CHOI, SU., LEE, CO., NO, ZS., KIM, SK., AHN, JW. HYDROLYZABLE TANNINS AND RELATED COMPOUND HAVING CYTOTOXIC ACTIVITY FROM THE FRUITS OF TERMINALIA-CHEBULA . Archives of pharmacal research, 1995, vol. 18, no. 2, p. 118-120. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature